tecentriq hybreza
(atezolizumab and hyaluronidase-tqjs)Genentech, Inc.
Usage: TECENTRIQ HYBREZA is indicated for treating various cancers, including non-small cell lung cancer (NSCLC), small cell lung cancer (ES-SCLC), unresectable or metastatic hepatocellular carcinoma (HCC), BRAF V600 mutation-positive melanoma, and unresectable or metastatic alveolar soft part sarcoma (ASPS) in adults.